(Q53609459)

English

Fas, Fas-associated death domain-like interleukin 1beta-converting enzyme-like inhibitory protein, and apoptotic features of elderly acute myeloid leukemia based on response to induction chemotherapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Fas, Fas-associated death domain-like interleukin 1beta-converting enzyme-like inhibitory protein, and apoptotic features of elderly acute myeloid leukemia based on response to induction chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

apoptotic process

0 references

0 references

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Hee-Je Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Byung-Hee Park

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Young Choi

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Woo-Sung Min

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Jong-Wook Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Chun-Choo Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

82

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

327-332

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

https://scigraph.springernature.com/pub.10.1532/ijh97.a30503

0 references

Fas receptor (CD95)-mediated apoptosis in leukemic cells

1 reference

https://api.crossref.org/works/10.1532%2FIJH97.A30503

21 January 2018

Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional analysis of apoptosis induction in acute myeloid leukaemia-relevance of karyotype and clinical treatment response

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia in the older patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypocellular acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organiz

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission of third recurrence of acute myeloid leukemia after treatment with imatinib (STI-571).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16298825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.A30503

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16298825

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53609459&oldid=1534961592"